Free Trial

Canopy Growth (TSE:WEED) Stock Price Up 9.6%

Canopy Growth Corp (TSE:WEED - Get Free Report) shares rose 9.6% during mid-day trading on Thursday . The company traded as high as C$15.03 and last traded at C$14.75. Approximately 1,718,279 shares were traded during trading, a decline of 41% from the average daily volume of 2,895,475 shares. The stock had previously closed at C$13.46.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the company. Bank of America reduced their target price on Canopy Growth from C$7.00 to C$4.00 in a research note on Wednesday, February 14th. Sanford C. Bernstein lifted their price objective on shares of Canopy Growth from C$1.49 to C$6.70 in a report on Tuesday, January 30th. Finally, Jefferies Financial Group lowered their target price on Canopy Growth from C$7.28 to C$4.90 and set a "hold" rating for the company in a report on Tuesday, February 27th.

Get Our Latest Analysis on WEED

Canopy Growth Stock Performance

The stock has a market cap of C$1.12 billion, a P/E ratio of -0.70, a price-to-earnings-growth ratio of -0.01 and a beta of 1.85. The company has a debt-to-equity ratio of 127.28, a quick ratio of 2.32 and a current ratio of 1.79. The firm's 50 day moving average is C$10.56 and its 200 day moving average is C$6.16.

Canopy Growth Company Profile

(Get Free Report)

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.

Read More

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Should you invest $1,000 in Canopy Growth right now?

Before you consider Canopy Growth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.

While Canopy Growth currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Featured Articles and Offers

Search Headlines: